acetaminophen has been researched along with s 1743 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anneveld, B; de Koning, BA; de Wildt, SN; Hanff, LM; Havenaar, R; Lelieveld, JP; Minekus, M; Mooij, MG | 1 |
| Bartoli, F; Blagojevic, J; Bruni, C; Cometi, L; Fiori, G; Furst, DE; Galluccio, F; Matucci Cerinic, M; Tofani, L | 1 |
| Li, PH | 1 |
1 trial(s) available for acetaminophen and s 1743
| Article | Year |
|---|---|
In vitro gastrointestinal model (TIM) with predictive power, even for infants and children?
Topics: Acetaminophen; Biological Availability; Child; Diclofenac; Esomeprazole; Gastrointestinal Tract; Humans; Infant; Infant, Newborn; Models, Biological | 2013 |
2 other study(ies) available for acetaminophen and s 1743
| Article | Year |
|---|---|
Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
Topics: Acetaminophen; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chlorpheniramine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Female; Humans; Hydrocortisone; Hydroxyzine; Infliximab; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Premedication; Ranitidine; Retrospective Studies; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Skin testing for hypersensitivity and cross-reactivity between proton pump inhibitors.
Topics: Acetaminophen; Adult; Cross Reactions; Diagnosis, Differential; Drug Hypersensitivity; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Humans; Proton Pump Inhibitors; Skin Tests | 2020 |